Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable Event

Publisher： Karger

E-ISSN： 1423-0194|104|3|273-279

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.104, Iss.3, 2016-05, pp. : 273-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short- and Long-Term Efficacy of Combined Cabergoline and Octreotide Treatment in Controlling IGF-I Levels in Acromegaly

By  

Neuroendocrinology, Vol. 92, Iss. 2, 2010-08 ,pp. : 120-127

Karger

Access to resources Recommend Favorite

Optimizing Medical Therapy of Acromegaly: Beneficial Effects of Cabergoline in Patients Uncontrolled with Long-Acting Release Octreotide

By  

Neuroendocrinology, Vol. 90, Iss. 1, 2009-05 ,pp. : 82-92

Karger

Access to resources Recommend Favorite

Short-Term Growth after Withdrawal of Exogenous Glucocorticoids

By  

Hormone Research in Paediatrics, Vol. 64, Iss. 3, 2005-10 ,pp. : 116-118

Karger

Access to resources Recommend Favorite

Long-Term Normal Renal Function after Drastic Weight Reduction in Patients with Obesity-Related Glomerulopathy

By  

Obesity Facts, Vol. 8, Iss. 3, 2015-05 ,pp. : 188-199

Karger

Access to resources Recommend Favorite

Has Triiodothyronine Treatment of Children after Cardiopulmonary Bypass Surgery Any Long-Term Effects?

By  

Hormone Research in Paediatrics, Vol. 84, Iss. 2, 2015-05 ,pp. : 137-138

Karger

Access to resources Recommend Favorite